Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition
AssigneeNitto Denko Corporation
InventorsTakuya Shishido, Daisuke Asari, Kyohei Matsushita, Mitsuhiko Hori
Life of this patent
Estimating the term…
Abstract
The present invention aims to provide a composition for promoting humoral immunity induction and a vaccine pharmaceutical composition that can be universally used for various antigens in inducing humoral immunity to antigens, contain a Th2 reaction promoter, and exerts a high humoral immunity inducing effect. The present invention relates to a vaccine pharmaceutical composition containing an antigen for humoral immunity induction and at least one Th2 reaction promoter.
Claims3
A method for promoting humoral immunity induction in a subject in need thereof, comprising:
- administering to the subject an effective amount of a G protein-coupled receptor (GPCR) ligand that is at least one selected from an antagonist for a Gi-coupled GPCR and an antagonist for a Gq-coupled GPCR.
A method for promoting humoral immunity induction in a subject in need thereof, comprising:
- administering to the subject an effective amount of a pharmaceutical composition comprising:
- an antigen for humoral immunity induction;
- and
- a G protein-coupled receptor (GPCR) ligand that is at least one selected from an antagonist for a Gi-coupled GPCR and an antagonist for a Gq-coupled GPCR.
Dependencies are inferred from the claim text.